Deep search
Profile Picture
  • All
  • Search
  • Copilot
  • Images
  • Videos
  • Maps
  • News
  • More
    • Shopping
    • Flights
    • Travel
    • Hotels
  • Notebook
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Business
  • More
    Politics
Order byBest matchMost fresh
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days

News

Regeneron to acquire 23andMe assets for $256 million

Digest more
Regeneron Acquires Bankrupt 23andMe's Assets for $256 Million Amidst Potential Layoffs in San Francisco
Regeneron Pharmaceuticals is acquiring the assets of 23andMe for $256 million, excluding its Lemonaid Health business, as the company faces layoffs and office closure due to financial struggles and a past cyberattack.

Continue reading

Hoodline · 4h
Tampa Free Press on MSN · 6h
Regeneron To Acquire 23andMe In Bankruptcy Sale, Sparking Data Privacy Concerns
 · 11h · on MSN
Regeneron agrees to buy bankrupt 23andMe, promises ethical use of customers' DNA data
11h
Timeline: 23andMe’s Journey From DNA Testing Pioneer to Bankruptcy Sale
What happened to 23andMe? Here's a look at its history from launch to bankruptcy and acquisition by Regeneron.
Rolling Out
10h
The fall of 23andMe and what it means for your DNA
The fall of 23andMe raises privacy concerns as Regeneron buys its genetic database for $256M after bankruptcy.
8don MSN
23andMe customers notified of bankruptcy and potential claims — deadline to file is July 14
Me, the genetic testing giant once valued in the billions, is now navigating Chapter 11 bankruptcy and notifying millions of ...
10d
OK AG Drummond issues consumer alert for 23andMe customers
Oklahoma Attorney General Gentner Drummond issued a consumer alert for concerned 23andMe customers after the genetic testing ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results
Feedback
© 2025 Microsoft
  • Privacy and Cookies
  • Legal
  • Advertise
  • About our ads
  • Help
  • Feedback
  • Your Privacy Choices
  • Consumer Health Privacy